Swedish Tax Agency decision on aquisition cost of XVIVO Perfusion shares.

  • 17:19

Allotment of acquisition cost XVIVO Perfusion decided by the Swedish Tax Agency.

In connection with Vitrolife’s distribution of the shares in Xvivo Perfusion AB, the Swedish Tax Agency has decided that 77% of the acquisition cost should be allotted to Vitrolife AB and 23% to Xvivo Perfusion AB.

Further information can be found on the Swedish Tax Agency’s website (www.skatteverket.se)